Clinical trial
Evaluation of the Efficacy & Safety of Topical Ivermectin Alone or in Combination With Microneedling as Novel Therapeutic Options for Cutaneous Non-genital Warts Versus Topical Salicylic Acid ؛ Randomized Controlled Clinical Trial.
NCT07396714 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy & Safety of Topical Ivermectin Alone or in Combination With Microneedling as Novel Therapeutic Options for Cutaneous Non-genital Warts Versus Topical Salicylic Acid ؛ Randomized Controlled Clinical Trial.
- Lead sponsor
- Assiut University
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- February 1, 2026
- Completion date
- June 1, 2027
- Enrollment
- 88 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.